Sep 29

QP 28 - Actionable Biomarkers: Guiding Therapy Selection and De-escalation

1163 - Beyond NCCN: How a Prognostic and Predictive Multimodal AI Biomarker Drives ADT De-Escalation In Prostate Cancer

05:05pm - 05:10pm ET

Presenter(s)

Eric Wegener, MBBS - Genesis Cancer Care, Newcastle, NSW